- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
ABCD Technologies buys 66 percent stake in AWACS
New Delhi: ABCD Technologies has, through its wholly-owned entity DigiHealth Technologies, acquired 66.02 per cent ownership interest in market research firm AIOCD Pharmasofttech Awacs, several pharma firms said in regulatory filings on Wednesday.
"Our investee entity i.e. ABCD Technologies LLP (to be renamed as IndoHealth Services LLP) has through its wholly-owned entity DigiHealth Technologies LLP, acquired 66.02 percent ownership interest in AIOCD Pharmasofttech Awacs Private Ltd (AWACS)", various pharma firms, including Cipla, Torrent Pharma, Dr Reddy's and Cadila Healthcare, said in regulatory filings.
They added that the acquisition has taken place through a combination of direct purchase of 50 per cent ownership interest in AWACS and indirect purchase of 16.02 per cent ownership interest in AWACS, through acquisition of 32.04 per cent shareholding interest in Trikaal Mediinfotech Pvt Ltd.
It is also agreed to acquire the balance stake subject to fulfilment of certain terms and conditions, they added.
AWACS is engaged in the business of pharmaceutical data collection and market research, the filings said.
Trikaal is 50 per cent owner of AWACS and holds certain intellectual property in relation to AWACS' business, they added.
The acquisition of 33.44 percent of the shareholding in AWACS (indirect) is envisaged to be completed over the course of the next few months, subject to fulfilment of certain terms and conditions, the filings said.
The remaining 0.54 per cent of the shareholding in AWACS (indirect) is likely to be acquired after 5 years, they added.
"The cost of acquisition for the combined transaction of AWACS and Trikaal is about Rs 75 crore for acquisition of a 100 per cent stake in AWACS and Trikaal (direct and indirect together)," the filings said.
abcd technologiesdigihealth technologiesaiocd pharmasofttech awacstrikaal mediinfotechacquisitionindohealth services
Source : PTIRuchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751
Next Story